Olaregen Therapeutix Inc.
Biotechnology company · New York, United States
Olaregen Therapeutix Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $450,000 sold in a notice filed in 2018.
Olaregen Therapeutix at a glance
What does Olaregen Therapeutix do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $450,000 sold (2018).
Frequently asked questions about Olaregen Therapeutix
Where is Olaregen Therapeutix headquartered?
Olaregen Therapeutix Inc. is headquartered in New York, United States.
What does Olaregen Therapeutix do?
Olaregen Therapeutix Inc. is a biotechnology company.
When was Olaregen Therapeutix founded?
The earliest incorporation on record for Olaregen Therapeutix Inc. is in 2017, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences